Full-Time

RCM Specialist: Appeals & Refunds

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Junior, Mid

Chicago, IL, USA

Hybrid position requiring in-office presence.

Category
Risk Management
Finance & Banking
Required Skills
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Bachelor's degree in healthcare administration, business, or a related field (or equivalent experience).
  • 2+ years of experience in healthcare denials/refunds/appeals, healthcare consulting, revenue cycle management, healthcare operations, or related fields.
  • Familiarity with healthcare reimbursement, payer policies, and regulatory compliance in the revenue cycle.
  • Experience in Microsoft Excel and other data analysis tools.
  • Detail-oriented with a commitment to accuracy and thoroughness in all tasks.
  • Excellent communication skills, both verbal and written, with the ability to convey complex ideas and analysis results clearly.
  • Proven ability to manage multiple projects simultaneously and prioritize tasks effectively.
  • Motivated self-starter with a proactive approach to problem-solving and driving continuous improvement.
Responsibilities
  • Monitor worklists for denials, refunds, and appeals in Tempus’ billing system.
  • Ensure timely submission and follow-up of appeals.
  • Monitor trends in denials, refunds, and appeals using reporting and dashboarding tools.
  • Identify and catalog pertinent payer policies impacting denials, refunds, and appeals.
  • Assist with creating and compiling appeal letters and supporting documentation.
  • Conduct pertinent research and present suggestions for improving revenue cycle management (RCM) KPIs.
  • Review and manage write-off worklists.
  • Handle ad hoc requests and special projects as needed, demonstrating flexibility and adaptability to meet evolving business needs.

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data, helping physicians make better treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights.

Company Stage

Series G

Total Funding

$1.3B

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

33%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tempus's IPO and significant revenue generation indicate strong financial health and growth potential.
  • Collaborations with industry giants like SoftBank and United Therapeutics can lead to groundbreaking advancements and increased market share.
  • The company's focus on personalized therapy and AI-driven insights can significantly improve patient outcomes, making it a rewarding place to work for those passionate about healthcare innovation.

What critics are saying

  • The lawsuit from Guardant Health over patent infringement could result in financial and reputational damage.
  • Operating in a highly competitive market with peers like Foundation Medicine and Guardant Health requires continuous innovation to maintain a competitive edge.

What makes Tempus unique

  • Tempus leverages AI to provide actionable insights from medical data, setting it apart from competitors who may not integrate AI as deeply into their platforms.
  • Their focus on personalized therapy options and extensive cancer research, including a pan-cancer organoid platform and liquid biopsy assay, distinguishes them in the healthcare tech space.
  • Tempus's collaboration with major firms like SoftBank and United Therapeutics highlights its strong industry partnerships and credibility.

Help us improve and share your feedback! Did you find this helpful?